Rationale: T-helper type 2 (Th2) inflammation, mediated by IL-4, IL-5, and IL-13, is considered
the central molecular mechanism underlying asthma, and Th2 cytokines are emerging …

Asthma is an increasingly common disease that remains poorly understood and difficult to
manage. This disease is characterized by airway hyperreactivity (AHR, defined by …

Background: The diagnosis of sarcoidosis is not standardized but is based on three major
criteria: a compatible clinical presentation, finding nonnecrotizing granulomatous inflammation …

Rationale: The American Thoracic Society/European Respiratory Society International
Consensus Classification panel identified the clinical entity idiopathic nonspecific interstitial …

Background Risk prediction is challenging in chronic interstitial lung disease (ILD) because
of heterogeneity in disease-specific and patient-specific variables. Our objective was to …

Introduction: A Case Control Etiology of Sarcoidosis Study (ACCESS) sarcoidosis organ
assessment instrument has been used for more than a decade to establish uniform standards …

The aim of this study was to determine the prevalence, characteristics and outcomes of
patients with unclassifiable interstitial lung disease (ILD) and to develop a simple method of …

Rationale: Pulmonary sarcoidosis is classically defined by T-helper (Th) cell type 1 inflammation
(eg, IFN-γ production by CD4 + effector T cells). Recently, IL-17A–secreting cells have …

Pulmonary function tests permit accurate, reproducible assessment of the functional state of
the respiratory system. It is worth emphasizing that pulmonary function tests do not diagnose …

Although often regarded as a protean illness with myriad clinical and imaging manifestations,
neurosarcoidosis typically presents as recognizable syndromes that can be approached in …